Evaluating a new test for blood disorders

A structured evaluation of a lateral flow test to monitor monoclonal gammopathy compared to standard of care serum testing to improve early diagnosis of myeloma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN69711307

Enrollment

500

Registered

2026-05-29

Start date

2026-02-10

Completion date

Unknown

Last updated

2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monoclonal gammopathies Other

Interventions

The MySELF study is an observational, prospective cohort study which identifies patients who will be having blood taken via phlebotomy for sPEP and sFLC testing, as part of their planned clinical care

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age >18 years 2. Undergoing sPEP and sFLC serum testing as part of routine clinical care 3. Willing to undergo finger prick blood sampling 4. Able to provide informed consent

Exclusion criteria

Exclusion criteria: 1. Outside of stated age range 2. Unable or unwilling to provide informed consent

Countries

England, United Kingdom

Contacts

Public ContactTracey Chan

tracey.chan@uhb.nhs.uk+44 121 371 9501

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 11, 2026